Mwangana Mubita

Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

Brian Godman, Holly McCabe, Trudy Leong et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2020 · 92 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications

M. M. Nashilongo, Bonifasius Siyuka Singu, Francis Kalemeera et al. · Cardiovascular Drugs and Therapy · 2017 · 89 citations · Full text

Pharmacy, Family Medicine, Health Assessment +16

Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications

S. Nakwatumbah, Dan Kibuule, B. Godman et al. · Expert Review of Anti-infective Therapy · 2017 · 69 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +12

Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future

Brian Godman, Debashis Basu, Yogan Pillay et al. · Hospital Practice · 2020 · 53 citations

Medicine, Health Policy, Internal Medicine +17

An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications

Dan Kibuule, Mwangana Mubita, Ester Naikaku et al. · International Journal of Clinical Practice · 2017 · 26 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17